EAST BOOTHBAY (AP) — A Maine ocean science laboratory and the University of Mississippi say their collaboration to identify new antimicrobial compounds with disease treating potential is yielding results.
The university and the Bigelow Laboratory for Ocean Sciences began the five-year partnership in 2013. The laboratory says its National Center for Marine Algae and Microbiota has provided 200 strains for screening for potential treatments for malaria and possibly some forms of cancer.
Algae center director Mike Lomas says the next step is to grow potential new compounds in large enough quantities that more analysis and testing can be completed. University of Mississippi’s nuclear magnetic resonance imaging equipment is being used as part of the effort.
Bigelow is offering 3,000 algal strains for experimentation as part of the project.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less